TAVR: State of the Field - What is Next for TAVR…Asymptomatic, Moderate AS or Severe AR?

Monday, February 27, 2023

9:40 AM – 9:50 AM ET

Speaker(s)

Eberhard Grube, MD, FSCAI

Head CIIC
University Hospital Bonn
Siegburg, Nordrhein-Westfalen, Germany

Disclosure(s): Ancora: Equity Interest (Ongoing); Boston Scientific: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); CardioMech: Equity Interest (Ongoing); Cardiovalve: Equity Interest (Ongoing); Claret: Equity Interest (Ongoing); HighLife: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Imperative Care: Equity Interest (Ongoing); Jena Valve: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Laminar: Equity Interest (Ongoing); Medtronic: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Millipede: Equity Interest (Ongoing); Pi-Cardia: Equity Interest (Ongoing); Protembis: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Reniva Medical: Equity Interest (Ongoing); Shockwave: Equity Interest (Ongoing); Valve medical: Equity Interest (Ongoing)

Disclosure(s):

Eberhard Grube, MD, FSCAI: Ancora: Equity Interest (Ongoing); Boston Scientific: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); CardioMech: Equity Interest (Ongoing); Cardiovalve: Equity Interest (Ongoing); Claret: Equity Interest (Ongoing); HighLife: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Imperative Care: Equity Interest (Ongoing); Jena Valve: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Laminar: Equity Interest (Ongoing); Medtronic: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Millipede: Equity Interest (Ongoing); Pi-Cardia: Equity Interest (Ongoing); Protembis: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Reniva Medical: Equity Interest (Ongoing); Shockwave: Equity Interest (Ongoing); Valve medical: Equity Interest (Ongoing)